{"slideshow_credits": null, "snippet": "The life and materials sciences company Royal DSM said on Tuesday that it would form a joint venture with the New York private equity firm JLL Partners.", "abstract": "The life and materials sciences company Royal DSM said on Tuesday that it would form a joint venture with the New York private equity firm JLL Partners.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Chad", "role": "reported", "lastname": "BRAY", "rank": 1, "organization": ""}], "original": "By CHAD BRAY"}, "web_url": "http://dealbook.nytimes.com/2013/11/19/dutch-firm-to-spin-off-drug-making-business-in-2-6-billion-deal/", "lead_paragraph": null, "headline": {"main": "Dutch Firm to Spin Off Drug-Making Business in $2.6 Billion Deal", "print_headline": "An Unusual Spinoff", "kicker": "DealBook"}, "_id": "528b342f38f0d833dcdeeaa5", "word_count": "505", "multimedia": [{"height": 126, "url": "images/2013/11/20/business/dbpix-royal-dsm/dbpix-royal-dsm-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/11/20/business/dbpix-royal-dsm/dbpix-royal-dsm-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 416, "url": "images/2013/11/20/business/dbpix-royal-dsm/dbpix-royal-dsm-articleLarge.jpg", "legacy": {"xlarge": "images/2013/11/20/business/dbpix-royal-dsm/dbpix-royal-dsm-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "416"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2013/11/20/business/dbpix-royal-dsm/dbpix-royal-dsm-thumbStandard.jpg", "legacy": {"thumbnail": "images/2013/11/20/business/dbpix-royal-dsm/dbpix-royal-dsm-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2013-11-19T04:45:57Z", "source": "The New York Times", "news_desk": null, "keywords": [{"name": "persons", "value": "Mullen, Jim", "rank": "1"}, {"name": "organizations", "value": "Patheon Incorporated", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}, {"name": "subject", "value": "Private Equity", "rank": "3"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}